Advertisement
Screener

ProQR Therapeutics N.V. (PRQR) Profit Loss Before Tax

1.9 / 5 stars · 15/40 Roast Me

ProQR Therapeutics N.V. Profit Loss Before Tax

ProQR Therapeutics N.V. (PRQR) reported Profit Loss Before Tax of -EUR 42.16 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.

Financial Statements › Notes

ifrs-full:ProfitLossBeforeTax · last filed 2026-03-12

  • ProQR Therapeutics N.V. profit loss before tax for the quarter ending 2025-12-31 was -8.92M EUR.
  • ProQR Therapeutics N.V. profit loss before tax for the quarter ending 2025-09-30 was -11.01M EUR.
  • ProQR Therapeutics N.V. profit loss before tax for the quarter ending 2025-06-30 was -12.16M EUR.
  • ProQR Therapeutics N.V. profit loss before tax for the quarter ending 2025-03-31 was -10.08M EUR.
Period endProfit Loss Before Tax 3 monthProfit Loss Before Tax 3 month as first filedProfit Loss Before Tax 6 monthProfit Loss Before Tax 6 month as first filedProfit Loss Before Tax 9 monthProfit Loss Before Tax 9 month as first filedProfit Loss Before Tax 12 monthProfit Loss Before Tax 12 month as first filed
2025-12-31-8.92M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12
-19.93M EUR
derived: sum of 2 quarters · filed 2026-03-12
-32.09M EUR
derived: sum of 3 quarters · filed 2026-03-12
-42.16M EUR
20-F · filed 2026-03-12
2025-09-30-11.01M EUR
6-K · filed 2025-11-06
-23.17M EUR
derived: sum of 2 quarters · filed 2025-11-06
-33.25M EUR
6-K · filed 2025-11-06
-42.55M EUR
derived: sum of 4 quarters · filed 2026-03-12
2025-06-30-12.16M EUR
6-K · filed 2025-08-07
-22.24M EUR
6-K · filed 2025-08-07
-31.55M EUR
derived: sum of 3 quarters · filed 2026-03-12
-39.65M EUR
derived: sum of 4 quarters · filed 2026-03-12
2025-03-31-10.08M EUR
6-K · filed 2025-05-08
-19.38M EUR
derived: sum of 2 quarters · filed 2026-03-12
-27.49M EUR
derived: sum of 3 quarters · filed 2026-03-12
-30.38M EUR
derived: sum of 4 quarters · filed 2026-03-12
2024-12-31-9.30M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12
-17.41M EUR
derived: sum of 2 quarters · filed 2026-03-12
-20.30M EUR
derived: sum of 3 quarters · filed 2026-03-12
-27.96M EUR
20-F · filed 2026-03-12
2024-09-30-8.11M EUR
6-K · filed 2025-11-06
-11.00M EUR
derived: sum of 2 quarters · filed 2025-11-06
-18.66M EUR
6-K · filed 2025-11-06
-24.13M EUR
derived: sum of 4 quarters · filed 2026-03-12
2024-06-30-2.89M EUR
6-K · filed 2025-08-07
-10.55M EUR
6-K · filed 2025-08-07
-16.02M EUR
derived: sum of 3 quarters · filed 2026-03-12
-21.49M EUR
derived: sum of 4 quarters · filed 2026-03-12
2024-03-31-7.66M EUR
6-K · filed 2025-05-08
-13.13M EUR
derived: sum of 2 quarters · filed 2026-03-12
-18.59M EUR
derived: sum of 3 quarters · filed 2026-03-12
-26.61M EUR
derived: sum of 4 quarters · filed 2026-03-12
2023-12-31-5.48M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12
-10.94M EUR
derived: sum of 2 quarters · filed 2026-03-12
-18.96M EUR
derived: sum of 3 quarters · filed 2026-03-12
-27.81M EUR
20-F · filed 2026-03-12
2023-09-30-5.46M EUR
6-K · filed 2024-11-07
-13.48M EUR
derived: sum of 2 quarters · filed 2024-11-07
-22.34M EUR
6-K · filed 2024-11-07
-35.63M EUR
derived: sum of 4 quarters · filed 2025-03-13
2023-06-30-8.02M EUR
6-K · filed 2024-08-08
-16.87M EUR
6-K · filed 2024-08-08
-30.17M EUR
derived: sum of 3 quarters · filed 2025-03-13
-53.41M EUR
derived: sum of 4 quarters · filed 2025-03-13
2023-03-31-8.86M EUR
6-K · filed 2024-05-09
-22.16M EUR
derived: sum of 2 quarters · filed 2025-03-13
-45.39M EUR
derived: sum of 3 quarters · filed 2025-03-13
-58.85M EUR
derived: sum of 4 quarters · filed 2025-03-13
2022-12-31-13.30M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13
-36.53M EUR
derived: sum of 2 quarters · filed 2025-03-13
-50.00M EUR
derived: sum of 3 quarters · filed 2025-03-13
-64.11M EUR
20-F · filed 2025-03-13
-64.80M EUR
20-F · filed 2023-03-29
2022-09-30-23.23M EUR
6-K · filed 2023-11-07
-24.31M EUR
6-K · filed 2022-11-09
-36.70M EUR
derived: sum of 2 quarters · filed 2023-11-07
-50.81M EUR
6-K · filed 2023-11-07
-53.41M EUR
6-K · filed 2022-11-09
-69.03M EUR
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-13.46M EUR
6-K · filed 2023-08-03
-14.65M EUR
6-K · filed 2022-08-04
-27.57M EUR
6-K · filed 2023-08-03
-29.09M EUR
6-K · filed 2022-08-04
-45.79M EUR
derived: sum of 3 quarters · filed 2023-08-03
-60.83M EUR
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31-14.11M EUR
6-K · filed 2023-05-16
-14.44M EUR
6-K · filed 2022-05-05
-32.33M EUR
derived: sum of 2 quarters · filed 2023-05-16
-47.36M EUR
derived: sum of 3 quarters · filed 2023-05-16
-63.06M EUR
derived: sum of 4 quarters · filed 2023-05-16
2021-12-31-18.22M EUR
6-K · filed 2022-02-24
-33.25M EUR
derived: sum of 2 quarters · filed 2022-11-09
-48.95M EUR
derived: sum of 3 quarters · filed 2022-11-09
-60.68M EUR
20-F · filed 2024-03-13
-61.56M EUR
6-K · filed 2022-02-24
2021-09-30-15.03M EUR
6-K · filed 2022-11-09
-30.73M EUR
derived: sum of 2 quarters · filed 2022-11-09
-43.34M EUR
6-K · filed 2022-11-09
-56.53M EUR
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-15.70M EUR
6-K · filed 2022-08-04
-28.31M EUR
6-K · filed 2022-08-04
-41.50M EUR
derived: sum of 3 quarters · filed 2022-08-04
-54.62M EUR
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-12.61M EUR
6-K · filed 2022-05-05
-25.80M EUR
derived: sum of 2 quarters · filed 2022-05-05
-38.91M EUR
derived: sum of 3 quarters · filed 2022-05-05
-43.02M EUR
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-13.19M EUR
6-K · filed 2022-02-24
-26.30M EUR
derived: sum of 2 quarters · filed 2022-02-24
-30.41M EUR
derived: sum of 3 quarters · filed 2022-02-24
-46.49M EUR
20-F · filed 2023-03-29
2020-09-30-13.11M EUR
6-K · filed 2021-11-04
-17.22M EUR
derived: sum of 2 quarters · filed 2021-11-04
-33.30M EUR
6-K · filed 2021-11-04
-51.81M EUR
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30-4.11M EUR
6-K · filed 2021-08-05
-20.19M EUR
6-K · filed 2021-08-05
-38.70M EUR
derived: sum of 3 quarters · filed 2021-08-05
-50.89M EUR
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-16.08M EUR
6-K · filed 2020-05-07
-34.59M EUR
derived: sum of 2 quarters · filed 2021-02-25
-46.78M EUR
derived: sum of 3 quarters · filed 2021-02-25
-58.45M EUR
derived: sum of 4 quarters · filed 2021-02-25
2019-12-31-18.51M EUR
6-K · filed 2021-02-25
-30.70M EUR
derived: sum of 2 quarters · filed 2021-02-25
-42.37M EUR
derived: sum of 3 quarters · filed 2021-02-25
-56.61M EUR
20-F · filed 2022-04-29
2019-09-30-12.19M EUR
6-K · filed 2020-11-16
-23.86M EUR
derived: sum of 2 quarters · filed 2020-11-16
-38.10M EUR
6-K · filed 2020-11-16
-51.08M EUR
derived: sum of 4 quarters · filed 2021-03-24
2019-06-30-11.67M EUR
6-K · filed 2020-08-06
-25.91M EUR
6-K · filed 2020-08-06
-38.89M EUR
derived: sum of 3 quarters · filed 2021-03-24
-44.88M EUR
derived: sum of 4 quarters · filed 2021-03-24
2019-03-31-14.24M EUR
6-K · filed 2020-05-07
-27.22M EUR
derived: sum of 2 quarters · filed 2021-03-24
-33.21M EUR
derived: sum of 3 quarters · filed 2021-03-24
-40.61M EUR
derived: sum of 4 quarters · filed 2021-03-24
2018-12-31-12.98M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24
-18.97M EUR
derived: sum of 2 quarters · filed 2021-03-24
-26.37M EUR
derived: sum of 3 quarters · filed 2021-03-24
-37.09M EUR
20-F · filed 2021-03-24
2018-09-30-5.99M EUR
6-K · filed 2019-11-12
-13.39M EUR
derived: sum of 2 quarters · filed 2019-11-12
-24.11M EUR
6-K · filed 2019-11-12
2018-06-30-7.40M EUR
6-K · filed 2019-08-07
-18.12M EUR
6-K · filed 2019-08-07
2017-12-31-43.67M EUR
20-F · filed 2020-03-31
2017-06-30-11.36M EUR
6-K · filed 2018-08-08
-21.84M EUR
6-K · filed 2018-08-08
2016-12-31-39.10M EUR
20-F · filed 2019-03-28
2015-12-31-20.83M EUR
20-F · filed 2018-03-30